NVP -bEZ235
NVP -bEZ235
To Order Contact us: caitlyn@ucb-bioproducts.com
![]() BEZ235 Tosylate |
|||
A3238-100 | ApexBio | 100 mg | EUR 151 |
Description: BEZ235 is an imidazoquinoline derivative inhibiting both PI3K and mTOR kinases with low nanomolar IC50s. It was well tolerated in preclinical animal studies as well as in clinical trials with manageable gastrointestinal side-effects[1, 2]. |
![]() BEZ235 Tosylate |
|||
A3238-500 | ApexBio | 500 mg | EUR 374 |
Description: BEZ235 is an imidazoquinoline derivative inhibiting both PI3K and mTOR kinases with low nanomolar IC50s. It was well tolerated in preclinical animal studies as well as in clinical trials with manageable gastrointestinal side-effects[1, 2]. |
![]() NVP-BGJ398 |
|||
2855-5 | Biovision | EUR 185 |
![]() NVP-BHG712 |
|||
2464-25 | Biovision | EUR 756 |
![]() NVP-BHG712 |
|||
2464-5 | Biovision | EUR 229 |
![]() NVP-BKM120 |
|||
2619-25 | Biovision | EUR 414 |
![]() NVP-BKM120 |
|||
2619-5 | Biovision | EUR 142 |
![]() NVP-AUY922 |
|||
1591-1 | Biovision | EUR 387 |
![]() NVP-AUY922 |
|||
1591-5 | Biovision | EUR 1072 |
![]() NVP-TAE684 |
|||
1683-5 | Biovision | EUR 272 |
![]() NVP-BEP800 |
|||
B2198-1 | Biovision | EUR 142 |
![]() NVP-BEP800 |
|||
B2198-5 | Biovision | EUR 414 |
![]() NVP-231 |
|||
B2225-25 | Biovision | EUR 349 |
![]() NVP-231 |
|||
B2225-5 | Biovision | EUR 131 |
![]() NVP-AEW541 |
|||
B1335-25 | Biovision | EUR 729 |
![]() NVP-AEW541 |
|||
B1335-5 | Biovision | EUR 240 |
![]() NVP-BAW2881 |
|||
HY-100394 | MedChemExpress | 100mg | EUR 785 |
![]() NVP-ADW742 |
|||
HY-10252 | MedChemExpress | 10mM/1mL | EUR 216 |
![]() NVP-2 |
|||
HY-12214A | MedChemExpress | 5mg | EUR 533 |
![]() NVP-BHG712 |
|||
HY-13258A | MedChemExpress | 50mg | EUR 807 |
![]() NVP-BAG956 |
|||
HY-13333 | MedChemExpress | 5mg | EUR 291 |
![]() NVP 231 |
|||
HY-13945 | MedChemExpress | 10mM/1mL | EUR 153 |
![]() NVP-TNKS656 |
|||
HY-13990 | MedChemExpress | 5mg | EUR 366 |
![]() NVP-BSK805 |
|||
HY-14722 | MedChemExpress | 10mg | EUR 340 |
![]() NVP-HSP990 |
|||
HY-15190 | MedChemExpress | 10mM/1mL | EUR 210 |
![]() NVP-LCQ195 |
|||
HY-15241 | MedChemExpress | 5mg | EUR 402 |
![]() NVP-BVU972 |
|||
HY-15456 | MedChemExpress | 10mg | EUR 483 |
![]() NVP-CGM097 |
|||
HY-15954 | MedChemExpress | 10mg | EUR 559 |
![]() NVP-ACC789 |
|||
HY-19624 | MedChemExpress | 10mM/1mL | EUR 189 |
![]() NVP-AEW541 |
|||
HY-50866 | MedChemExpress | 2mg | EUR 173 |
![]() NVP-AEW541 |
|||
E1KS1034 | EnoGene | 2mg | EUR 718 |
![]() NVP-ADW742 |
|||
E1KS1088 | EnoGene | 5 mg | EUR 874 |
![]() NVP-BEP800 |
|||
E1KS1498 | EnoGene | 5mg | EUR 874 |
![]() NVP-BHG712 |
|||
E1KS2202 | EnoGene | 5mg | EUR 874 |
![]() NVP-BSK805 |
|||
E1KS2686 | EnoGene | 5mg1 PHYSICAL AND CHEMICAL PROPERTIES | EUR 1111 |
![]() NVP-AEW541 |
|||
A2278-100 | ApexBio | 100 mg | EUR 885 |
Description: NVP-AEW541 is a novel, potent and selective inhibitor of IGF-IR kinase with IC50 value of 0.086 ?M [1]. NVP-AEW541 is a pyrrolo(2,3-d) pyrimidine derivative. |
![]() NVP-AEW541 |
|||
A2278-2 | ApexBio | 2 mg | EUR 154 |
Description: NVP-AEW541 is a novel, potent and selective inhibitor of IGF-IR kinase with IC50 value of 0.086 ?M [1]. NVP-AEW541 is a pyrrolo(2,3-d) pyrimidine derivative. |
![]() NVP-AEW541 |
|||
A2278-25 | ApexBio | 25 mg | EUR 432 |
Description: NVP-AEW541 is a novel, potent and selective inhibitor of IGF-IR kinase with IC50 value of 0.086 ?M [1]. NVP-AEW541 is a pyrrolo(2,3-d) pyrimidine derivative. |
![]() NVP-AEW541 |
|||
A2278-5 | ApexBio | 5 mg | EUR 189 |
Description: NVP-AEW541 is a novel, potent and selective inhibitor of IGF-IR kinase with IC50 value of 0.086 ?M [1]. NVP-AEW541 is a pyrrolo(2,3-d) pyrimidine derivative. |
![]() NVP-AEW541 |
|||
A2278-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 189 |
Description: NVP-AEW541 is a novel, potent and selective inhibitor of IGF-IR kinase with IC50 value of 0.086 ?M [1]. NVP-AEW541 is a pyrrolo(2,3-d) pyrimidine derivative. |
![]() NVP 231 |
|||
B1235-10 | ApexBio | 10 mg | EUR 241 |
Description: NVP 231 is a potent, reversible and specific inhibitor of ceramide kinase(CerK) with the IC50 value of 12±2nM in radio assay [1].NVP 231 has been noted to inhibit CerK with the IC50 value of 12±2nM and have the 90% inhibition at 100 nM in the radio assay. |
![]() NVP 231 |
|||
B1235-25 | ApexBio | 25 mg | EUR 398 |
Description: NVP 231 is a potent, reversible and specific inhibitor of ceramide kinase(CerK) with the IC50 value of 12±2nM in radio assay [1].NVP 231 has been noted to inhibit CerK with the IC50 value of 12±2nM and have the 90% inhibition at 100 nM in the radio assay. |
![]() NVP 231 |
|||
B1235-5 | ApexBio | 5 mg | EUR 154 |
Description: NVP 231 is a potent, reversible and specific inhibitor of ceramide kinase(CerK) with the IC50 value of 12±2nM in radio assay [1].NVP 231 has been noted to inhibit CerK with the IC50 value of 12±2nM and have the 90% inhibition at 100 nM in the radio assay. |
![]() NVP-ADW742 |
|||
B1584-10 | ApexBio | 10 mg | EUR 367 |
Description: NVP-ADW742 is a novel inhibitor of IFG-1receptor (IGF-1R) kinase with the IC50 value of 0.17?M [1].NVP-ADW742 has shown above 16-fold effective function against IGF-1R than insulin receptor (InsR). |
![]() NVP-ADW742 |
|||
B1584-5 | ApexBio | 5 mg | EUR 270 |
Description: NVP-ADW742 is a novel inhibitor of IFG-1receptor (IGF-1R) kinase with the IC50 value of 0.17?M [1].NVP-ADW742 has shown above 16-fold effective function against IGF-1R than insulin receptor (InsR). |
![]() NVP-ADW742 |
|||
B1584-50 | ApexBio | 50 mg | EUR 1389 |
Description: NVP-ADW742 is a novel inhibitor of IFG-1receptor (IGF-1R) kinase with the IC50 value of 0.17?M [1].NVP-ADW742 has shown above 16-fold effective function against IGF-1R than insulin receptor (InsR). |
![]() NVP-CGM097 |
|||
B4677-10 | ApexBio | 10 mg | EUR 667 |
![]() NVP-CGM097 |
|||
B4677-100 | ApexBio | 100 mg | EUR 3557 |
![]() NVP-CGM097 |
|||
B4677-5 | ApexBio | 5 mg | EUR 416 |
![]() NVP-CGM097 |
|||
B4677-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 627 |
![]() NVP-CGM097 |
|||
B4677-50 | ApexBio | 50 mg | EUR 2388 |
![]() NVP-TNKS656 |
|||
B6046-10 | ApexBio | 10 mg | EUR 773 |
Description: NVP-TNKS656 is an orally active antagonist of Wnt pathway activity. The Wnt pathway has been involved in controlling numerous developmental processes. Dysfunction of this pathway may result in carcinogenesis [1]. |
![]() NVP-TNKS656 |
|||
B6046-100 | ApexBio | 100 mg | EUR 3306 |
Description: NVP-TNKS656 is an orally active antagonist of Wnt pathway activity. The Wnt pathway has been involved in controlling numerous developmental processes. Dysfunction of this pathway may result in carcinogenesis [1]. |
![]() NVP-TNKS656 |
|||
B6046-25 | ApexBio | 25 mg | EUR 1298 |
Description: NVP-TNKS656 is an orally active antagonist of Wnt pathway activity. The Wnt pathway has been involved in controlling numerous developmental processes. Dysfunction of this pathway may result in carcinogenesis [1]. |
![]() NVP-TNKS656 |
|||
B6046-5 | ApexBio | 5 mg | EUR 466 |
Description: NVP-TNKS656 is an orally active antagonist of Wnt pathway activity. The Wnt pathway has been involved in controlling numerous developmental processes. Dysfunction of this pathway may result in carcinogenesis [1]. |
![]() NVP-TNKS656 |
|||
B6046-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 502 |
Description: NVP-TNKS656 is an orally active antagonist of Wnt pathway activity. The Wnt pathway has been involved in controlling numerous developmental processes. Dysfunction of this pathway may result in carcinogenesis [1]. |
![]() NVP-TNKS656 |
|||
B6046-50 | ApexBio | 50 mg | EUR 2222 |
Description: NVP-TNKS656 is an orally active antagonist of Wnt pathway activity. The Wnt pathway has been involved in controlling numerous developmental processes. Dysfunction of this pathway may result in carcinogenesis [1]. |
![]() NVP-BAG956 |
|||
A3672-10 | ApexBio | 10 mg | EUR 312 |
Description: NVP-BAG956(BAG 956) is a potent, ATP-competitive and selective dual PI3K and PDK1 inhibitor in vitro and in vivo,with IC50 values to be 56, 444, 34, 117 and 240 nM for PI3K p110 alpha, beta, delta and gamma and PDK1 kinases, respectively. |
![]() NVP-BAG956 |
|||
A3672-5 | ApexBio | 5 mg | EUR 221 |
Description: NVP-BAG956(BAG 956) is a potent, ATP-competitive and selective dual PI3K and PDK1 inhibitor in vitro and in vivo,with IC50 values to be 56, 444, 34, 117 and 240 nM for PI3K p110 alpha, beta, delta and gamma and PDK1 kinases, respectively. |
![]() NVP-BSK805 |
|||
A3675-10 | ApexBio | 10 mg | EUR 316 |
Description: NVP-BSK805 is a potent and selective inhibitor of JAK2 with IC50 value of 0.58 nM [1].Janus kinase 2 (JAK2) is a member of the JAK family and is a non-receptor tyrosine kinase. |
![]() NVP-BSK805 |
|||
A3675-200 | ApexBio | 200 mg | EUR 2010 |
Description: NVP-BSK805 is a potent and selective inhibitor of JAK2 with IC50 value of 0.58 nM [1].Janus kinase 2 (JAK2) is a member of the JAK family and is a non-receptor tyrosine kinase. |
![]() NVP-BSK805 |
|||
A3675-5 | ApexBio | 5 mg | EUR 247 |
Description: NVP-BSK805 is a potent and selective inhibitor of JAK2 with IC50 value of 0.58 nM [1].Janus kinase 2 (JAK2) is a member of the JAK family and is a non-receptor tyrosine kinase. |
![]() NVP-BSK805 |
|||
A3675-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 266 |
Description: NVP-BSK805 is a potent and selective inhibitor of JAK2 with IC50 value of 0.58 nM [1].Janus kinase 2 (JAK2) is a member of the JAK family and is a non-receptor tyrosine kinase. |
![]() NVP-BSK805 |
|||
A3675-50 | ApexBio | 50 mg | EUR 734 |
Description: NVP-BSK805 is a potent and selective inhibitor of JAK2 with IC50 value of 0.58 nM [1].Janus kinase 2 (JAK2) is a member of the JAK family and is a non-receptor tyrosine kinase. |
![]() NVP-BSK805 |
|||
A3675-S | ApexBio | Evaluation Sample | EUR 81 |
Description: NVP-BSK805 is a potent and selective inhibitor of JAK2 with IC50 value of 0.58 nM [1].Janus kinase 2 (JAK2) is a member of the JAK family and is a non-receptor tyrosine kinase. |
![]() NVP-LCQ195 |
|||
A3676-10 | ApexBio | 10 mg | EUR 466 |
Description: NVP-LCQ195 is a pan-inhibitor of CDKs [1].Cyclin-dependent kinases (CDKs) are a family of protein kinases and play an important role in regulating the cell cycle. They are also involved in regulating transcription, mRNA processing, and the differentiation of nerve cells. |
![]() NVP-LCQ195 |
|||
A3676-5 | ApexBio | 5 mg | EUR 347 |
Description: NVP-LCQ195 is a pan-inhibitor of CDKs [1].Cyclin-dependent kinases (CDKs) are a family of protein kinases and play an important role in regulating the cell cycle. They are also involved in regulating transcription, mRNA processing, and the differentiation of nerve cells. |
![]() NVP-BEP800 |
|||
A4064-10 | ApexBio | 10 mg | EUR 270 |
Description: NVP-BEP800 is a fully synthetic, orally bioavailable inhibitor of Hsp90 with IC50 value of 58nM [1].NVP-BEP800 binds to the N-terminal ATP-binding pocket of Hsp90. |
![]() NVP-BEP800 |
|||
A4064-100 | ApexBio | 100 mg | EUR 1163 |
Description: NVP-BEP800 is a fully synthetic, orally bioavailable inhibitor of Hsp90 with IC50 value of 58nM [1].NVP-BEP800 binds to the N-terminal ATP-binding pocket of Hsp90. |
![]() NVP-BEP800 |
|||
A4064-25 | ApexBio | 25 mg | EUR 525 |
Description: NVP-BEP800 is a fully synthetic, orally bioavailable inhibitor of Hsp90 with IC50 value of 58nM [1].NVP-BEP800 binds to the N-terminal ATP-binding pocket of Hsp90. |
![]() NVP-BEP800 |
|||
A4064-5 | ApexBio | 5 mg | EUR 177 |
Description: NVP-BEP800 is a fully synthetic, orally bioavailable inhibitor of Hsp90 with IC50 value of 58nM [1].NVP-BEP800 binds to the N-terminal ATP-binding pocket of Hsp90. |
![]() NVP-BGT226 |
|||
A8488-10 | ApexBio | 10 mg | EUR 363 |
Description: BGT226 (NVP-BGT226) is a novel inhibitor of PI3K/mTOR for PI3K?/?/? with IC50 of 4 nM/63 nM/38 nM. |
![]() NVP-BGT226 |
|||
A8488-5 | ApexBio | 5 mg | EUR 241 |
Description: BGT226 (NVP-BGT226) is a novel inhibitor of PI3K/mTOR for PI3K?/?/? with IC50 of 4 nM/63 nM/38 nM. |
![]() NVP-BGT226 |
|||
A8488-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 322 |
Description: BGT226 (NVP-BGT226) is a novel inhibitor of PI3K/mTOR for PI3K?/?/? with IC50 of 4 nM/63 nM/38 nM. |
![]() NVP-BGT226 |
|||
A8488-50 | ApexBio | 50 mg | EUR 920 |
Description: BGT226 (NVP-BGT226) is a novel inhibitor of PI3K/mTOR for PI3K?/?/? with IC50 of 4 nM/63 nM/38 nM. |
![]() NVP-BVU972 |
|||
A8489-10 | ApexBio | 10 mg | EUR 351 |
Description: NVP-BVU972 is a selective and potent inhibitor of c-Met with IC50 of 14 nM. Besides, NVP-BVU972 displays IC50 values more than 1000 nM in other kinases such as the most closely related kinase recepteur d'origine nantais (RON). |
![]() NVP-BVU972 |
|||
A8489-5 | ApexBio | 5 mg | EUR 270 |
Description: NVP-BVU972 is a selective and potent inhibitor of c-Met with IC50 of 14 nM. Besides, NVP-BVU972 displays IC50 values more than 1000 nM in other kinases such as the most closely related kinase recepteur d'origine nantais (RON). |
![]() NVP-BVU972 |
|||
A8489-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 305 |
Description: NVP-BVU972 is a selective and potent inhibitor of c-Met with IC50 of 14 nM. Besides, NVP-BVU972 displays IC50 values more than 1000 nM in other kinases such as the most closely related kinase recepteur d'origine nantais (RON). |
![]() NVP-BVU972 |
|||
A8489-50 | ApexBio | 50 mg | EUR 1036 |
Description: NVP-BVU972 is a selective and potent inhibitor of c-Met with IC50 of 14 nM. Besides, NVP-BVU972 displays IC50 values more than 1000 nM in other kinases such as the most closely related kinase recepteur d'origine nantais (RON). |
![]() NVP-BHG712 |
|||
A8683-10 | ApexBio | 10 mg | EUR 235 |
Description: NVP-BHG712 is a potent inhibitor of EphB4 and VEGFR2 with ED50 value of 25 nM and 4200 nM, respectively [1].Ephrin type-B receptor 4 (EphB4) is a protein and plays an important role in mediating a variety of developmental processes by working with its ligand. |
![]() NVP-BHG712 |
|||
A8683-200 | ApexBio | 200 mg | EUR 1790 |
Description: NVP-BHG712 is a potent inhibitor of EphB4 and VEGFR2 with ED50 value of 25 nM and 4200 nM, respectively [1].Ephrin type-B receptor 4 (EphB4) is a protein and plays an important role in mediating a variety of developmental processes by working with its ligand. |
![]() NVP-BHG712 |
|||
A8683-5 | ApexBio | 5 mg | EUR 148 |
Description: NVP-BHG712 is a potent inhibitor of EphB4 and VEGFR2 with ED50 value of 25 nM and 4200 nM, respectively [1].Ephrin type-B receptor 4 (EphB4) is a protein and plays an important role in mediating a variety of developmental processes by working with its ligand. |
![]() NVP-BHG712 |
|||
A8683-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 212 |
Description: NVP-BHG712 is a potent inhibitor of EphB4 and VEGFR2 with ED50 value of 25 nM and 4200 nM, respectively [1].Ephrin type-B receptor 4 (EphB4) is a protein and plays an important role in mediating a variety of developmental processes by working with its ligand. |
![]() NVP-BHG712 |
|||
A8683-50 | ApexBio | 50 mg | EUR 769 |
Description: NVP-BHG712 is a potent inhibitor of EphB4 and VEGFR2 with ED50 value of 25 nM and 4200 nM, respectively [1].Ephrin type-B receptor 4 (EphB4) is a protein and plays an important role in mediating a variety of developmental processes by working with its ligand. |
![]() NVP-BSK805 dihydrochloride |
|||
B2200-1 | Biovision | EUR 131 |
![]() NVP-TAE 684 |
|||
HY-10192 | MedChemExpress | 50mg | EUR 491 |
![]() NVP-TAE 226 |
|||
HY-13203 | MedChemExpress | 100mg | EUR 1675 |
![]() NVP-BHG712 isomer |
|||
HY-13258 | MedChemExpress | 50mg | EUR 1179 |